These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 8742940)

  • 1. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches.
    Mehdizadeh A; Toliate T; Rouini MR; Abashzadeh S; Dorkoosh F
    Acta Pharm; 2004 Dec; 54(4):301-17. PubMed ID: 15634614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro evaluation of a new fentanyl patch based on acrylic/silicone pressure-sensitive adhesive blends.
    Taghizadeh SM; Soroushnia A; Mirzadeh H; Barikani M
    Drug Dev Ind Pharm; 2009 Apr; 35(4):487-98. PubMed ID: 19043820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the transdermal permeation behavior of Proterguride from drug in adhesive matrix patches through hairless mouse skin.
    Schurad B; Tack J; Lipp R
    Drug Dev Ind Pharm; 2005 Jul; 31(6):505-13. PubMed ID: 16109623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
    Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
    Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
    Vora D; Banga AK
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation issues associated with transdermal fentanyl delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
    Roy SD; Manoukian E
    J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vitro evaluation of pentazocine transdermal delivery system.
    Furuishi T; Io T; Fukami T; Suzuki T; Tomono K
    Biol Pharm Bull; 2008 Jul; 31(7):1439-43. PubMed ID: 18591789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of adhesive properties and drug-adhesive interactions for transdermal drug delivery formulations using linear solvation energy relationships.
    Li J; Masso JJ; Rendon S
    J Control Release; 2002 Jul; 82(1):1-16. PubMed ID: 12106972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of fentanyl from matrix and reservoir systems: effect of heat and compromised skin.
    Prodduturi S; Sadrieh N; Wokovich AM; Doub WH; Westenberger BJ; Buhse L
    J Pharm Sci; 2010 May; 99(5):2357-66. PubMed ID: 19967778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch.
    Ganti SS; Bhattaccharjee SA; Murnane KS; Blough BE; Banga AK
    Int J Pharm; 2018 Oct; 550(1-2):71-78. PubMed ID: 30125654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I.
    Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
    Biol Pharm Bull; 2012; 35(3):321-8. PubMed ID: 22382317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of crystallization in drug-in-adhesive-type transdermal patches.
    Jain P; Banga AK
    Int J Pharm; 2010 Jul; 394(1-2):68-74. PubMed ID: 20438819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of buprenorphine through cadaver skin.
    Roy SD; Roos E; Sharma K
    J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release and Skin Permeation of Scopolamine From Thin Polymer Films in Relation to Thermodynamic Activity.
    Kunst A; Lee G
    J Pharm Sci; 2016 Apr; 105(4):1496-500. PubMed ID: 27019963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in transdermal penetration of fentanyl through equine skin.
    Mills PC; Cross SE
    Res Vet Sci; 2007 Apr; 82(2):252-6. PubMed ID: 17011603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.